Search results
Results from the WOW.Com Content Network
The stability-based methods below are thought to work due to ligand-induced shifts in equilibrium concentrations of protein conformational states. A single protein type in solution may be represented by individual molecules in a variety of conformations , with many of them different from one another despite being identical in amino acid sequence.
Proteomics enables the identification of ever-increasing numbers of proteins. This varies with time and distinct requirements, or stresses, that a cell or organism undergoes. [3] Proteomics is an interdisciplinary domain that has benefited greatly from the genetic information of various genome projects, including the Human Genome Project. [4]
There is limited protein sequence coverage by identified peptides, loss of labile PTMs, and ambiguity of the origin for redundant peptide sequences. [8] Recently the combination of bottom-up and top-down proteomics, so called middle-down proteomics, is receiving a lot of attention as this approach not only can be applied to the analysis of large protein fragments but also avoids redundant ...
Proteogenomics is a field of biological research that utilizes a combination of proteomics, genomics, and transcriptomics to aid in the discovery and identification of peptides. Proteogenomics is used to identify new peptides by comparing MS/MS spectra against a protein database that has been derived from genomic and transcriptomic information.
The Human Proteome Organization has served as a coordinating body for many long-running proteomics research projects associated with specific human tissues of clinical interest, such as blood plasma, [3] liver, [4] brain [5] and urine. [6]
Activity-based proteomics, or activity-based protein profiling (ABPP) is a functional proteomic technology that uses chemical probes that react with mechanistically related classes of enzymes. [ 1 ] Description
David B. Agus (/ ˈ eɪ ɡ ə s /) is an American physician, cancer researcher and author [1] who serves as a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering [2] and the Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine. [3]
Clinical Proteomics is a peer-reviewed open access medical journal published by BioMed Central. Covers scientific research in the field of translational proteomics with an emphasis on the application of proteomic technology to all aspects of clinical research. [ 1 ]